Gilead Sciences to Release Fourth Quarter & Full Year 2025 Financial Results on Tuesday, February 10, 2026
Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
earnings date
Key Terms
biopharmaceuticalmedical
A biopharmaceutical is a medicine made from living organisms or their components—such as proteins, cells or genetic material—rather than chemically synthesized compounds. For investors, these products can command high prices and long patent protection but also carry bigger development, manufacturing and regulatory risks; think of them like handcrafted, high-tech products that can generate strong returns if they work, but are costly and complex to produce.
HIVmedical
Human immunodeficiency virus (HIV) is a virus that gradually damages the body's infection-fighting system and can lead to serious illness if not treated. For investors, HIV matters because progress or setbacks in tests, treatments, or vaccines can change demand for medicines, affect regulatory approvals and patent value, and shift healthcare spending—similar to how a major technology breakthrough can reshape an entire industry’s market prospects.
viral hepatitismedical
Viral hepatitis is an infection of the liver caused by specific viruses that inflame and damage the organ, like a clog in an engine that reduces performance. It matters to investors because its prevalence and severity drive demand for diagnostics, treatments, and vaccines, influence healthcare costs and regulatory attention, and can materially affect the prospects and valuations of companies working on therapies or public-health responses.
COVID-19medical
COVID-19 is an infectious disease caused by the SARS‑CoV‑2 virus that can produce symptoms from mild respiratory illness to severe, life‑threatening complications. It matters to investors because outbreaks, containment measures, vaccination campaigns and treatments change consumer behavior, supply chains, labor availability and healthcare demand—like a sudden storm that reroutes traffic—altering company revenues, costs and overall market risk.
webcasttechnical
A webcast is a live or recorded online event where people watch or listen to presentations, announcements, or performances through the internet. It’s like a TV broadcast but over the internet, allowing viewers from anywhere to tune in in real time or later. Webcasts are important because they let companies share information quickly and widely with audiences around the world.
FOSTER CITY, Calif.--(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its fourth quarter and full year 2025 financial results and guidance will be released on Tuesday, February 10, 2026 after the market closes. At 4:30 p.m. Eastern Time that day, Gilead’s management will host a webcast to discuss the company’s fourth quarter and full year 2025 financial results and provide a business update.
A live webcast will be available in the Investors section of www.gilead.com and will be archived there for one year.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
